In both groups, patients with high bub1 expression showed lower overall survival rates than those with low bub1 expression (Figure 1C, p = 0.032, and Figure 1D, p = 0.083), further supporting the role of bub1 as an independent prognostic biomarker for neuroblastoma. The gene discussed is BUB1; the disease is neuroblastoma.